There is general agreement that group A haemolytic streptococcal infections of the upper respiratory tract are causally related to rheumatic fever. It is not understood why a few individuals develop rheumatic fever following such throat infections while most do not. This important question, the subject of many investigations most of which have been from an immunological point of view, remains without a satisfactory answer.
There is evidence to suggest that the presence of the mucopolysaccharide blood-group substances in saliva is related to susceptibility to rheumatic fever (Glynn and Holborow, 1961) . These authors have suggested (Glynn and Holborow, 1952) that streptococci possibly convert blood-group substances to antigens which might then participate in the pathogenesis of rheumatic fever.
The evidence suggesting an association between the ABO blood groups and rheumatic fever is not as strong as that for the association to ABO (H) secretion. If there is a blood-group association, it could (a) simply reflect the " effect " of a blood-group substance being secreted in the saliva as suggested above, or (b) it might reflect a more general "effect" of gene action on enzymatic activity and cellular metabolism.
In this report the present status of our studies dealing with the possible association of the blood groups to rheumatic fever is described. The previously reported data suggesting an ABO-blood-group association for rheumatic fever are included (Buckwalter et al., 1958 blood were: A, B, absorbed anti-A, Rh., rh', rh", hr', M, N, and anti-human. The techniques employed were those recommended by the supplier of the antisera. It is relevant to the results and important to point out that all the blood typings were performed by the same technician. An isohaemagglutination test, using anti-A and B sera and anti-O (H) in the form of a mixture made from ground Ulex europaeus seeds and 0.9% NaCl, was employed to determine the presence of bloodgroup substances in the saliva specimens.
Several different kinds of controls were used in ascertaining the statistical significance of the patient data. The 49,979 blood donors described in detail in a previous communication (Buckwalter and Knowler, 1958) were used to assess the total ABO findings (controls I). To evaluate the ABO subgroup (A1, A2, A1B. A,B), rhesus and MN blood groups, and salivasecretion data a random sample of physicians, students. technicians, spouses of the patients, and patients with diagnoses other than those being studied were used as controls (II). Unaffected siblings of the patients provided a third set of controls (III). In another communication the reasons for using unaffected siblings as controls for blood-group disease studies have been discussed (Buckwalter et al., 1960) .
A modification of the method described by Woolf (1955) has been used to arrive at the statistical significance of the data. This method evaluates the significance of the differences in the incidence of the disease in the patients of the different blood groups. The incidences are determined from the blood-type frequencies observed in the patients and the controls. This is a more direct and natural way to think of the blood-group association than in terms of an increase or decrease in the patients' blood-group frequencies compared with control blood-group frequencies. This method has the added advantage of making it possible to combine and analyse data collected by independent investigators. The use of two programmes which have been written for the IBM 7070 digital computer by Dr. Edwards greatly facilitates the statistical analysis of the data. The results obtained when the data are examined by the conventional x2 method are given in another communication (Buckwalter and Tweed, 1962) . A method devised by C. A. Smith, as described by Clarke et al. (1956) , was used in determining the statistical significance of the sibling data. Table V records the incidence of rheumatic fever in persons of A,, A29 B, A1B, A2B,and the combined non-0 blood groups relative to the incidence of the disease in group 0 persons (RI); the relative incidence (RI) of the disease in non-secretors to secretors is also shown.
ResuIlt
The x2 value for each of the comparisons is given. The data reveal a decreased incidence of rheumatic fever in persons of blood group 0. When the incidence in group 0 is compared with that in the other groups the largest differences are found for the 0: A and 0: non-0 comparisons. However, these differences are not statistically significant. None of the secretion: nonsecretion differences for specific blood groups using the patient and the control data recorded in Table IV are statistically significant (results of analysis are not shown).
However, when the secretion findings for the combined ABO blood groups of the patients and the controls are compared ( Table V) the incidence of the disease is found to be significantly increased in non-secretors-that is, the frequency of the non-secretion is significantly higher in the patients than in the controls. The unaffected siblings which were used as controls (III) were obtained from the families of the 157 rheumatic fever patients that segregated for group 0-that is, there were group 0 and non-O group siblings (r'r")r, and the combined non-rr genotypes has been compared with the incidence in persons of rr genotype.
The R2r: rr and the (r'r")r: rr differences are statistically significant, as indicated in Table VIII .
In Table IX are recorded the MN blood-group findings in the rheumatic-fever patients and controls.
The results obtained when these data are examined for The relative incidence of rheumatic fever in persons of Rh + and Rh -phenotypes does not significantly differ, as indicated by the non-rr to rr comparison in Table VIII . The rhesus " effect" becomes evident when the patients are grouped using rh', rh", and hr' in addition to the Rho antisera. The rhesus " effect," characterized by an increased incidence of the disease in persons of the R2r and (r'r")r presumptive genotypes, appears to be stronger than the ABO " effect." This is suggested by the larger differences between the patients and controls in the rhesus data, resulting in higher levels of statistical significance with fewer data. The differences between the patients and controls are similarly greater in the MN than in the ABO data.
The possibility has been suggested that the excess of patients compared with controls of the (r'r")r genotype might be due to a serological peculiarity which sometimes occurs with rheumatic fever. This possibility is being investigated by performing the appropriate additional serological tests upon the blood of the patients in question.
The associations between rheumatic fever and the ABO, rhesus, and MN blood-group systems raises the question of interaction between the blood-group systems. This possibility has been explored by comparing rhesus and MN blood-group frequencies of rheumatic-fever patients of 0 and non-O blood groups. No evidence of a statistically significant combined "effect" was (1960) . § Glynn and Holborow (1961) . MEDICAL JOURNAL found (Buckwalter and Tweed, 1962) . However, the volume of the data available for analysis is much too small to categorically rule out this possibility. It is also possible that combined " effects" exist with ABO (H) secretion, or with " effects" of the other blood-group systems which have not been investigated.
The findings presented and discussed appear to provide a definite and affirmative answer to the question: Is there an association between the blood groups and rheumatic fever ? However, in interpreting the meaning of the rheumatic-fever findings and the findings of all studies concerned with the association of blood groups and disease, it is important never to forget several criticisms of these researches. The first is related to the patient-material. The diagnoses in the patients who provided the material for this report were established by different clinicians on the basis of the usual criteria used in this disease. Undoubtedly patients have bcen included inadvertently who did not have rheuimatic fever. A second factor affecting the bloodtype frequencies in a way which cannot be measured is that some of the patients, in addition to having rheumatic fever, also had one or more other disorders, such as duodenal ulcer. In such patients there would be conflicting " blood-group effects " associated with multiple disorders. This factor cannot be eliminated by excluding patients with multiple disorders (less than 5% of the patients included in this report), since there are additional rheumatic-fever patients who are currently free of a second disorder but are nevertheless " genetically predisposed" to other disorders which ultimately will become clinically manifest. Finally, as has been suggested in this report, and by Buckwalter and Knowler (1958) , the controls for blood-group disease researches leave much to be desired.
If it be granted that a causal association exists between rheumatic fever and the blood groups, we are then confronted by the even more challenging and difficult questions related to the nature of the association. At the present time virtually nothing is known concerning the mechanisms responsible for the association in rheumatic fever or the associations between other diseases and the blood groups. The evidence for the associations in rheumatic fever is not as strong as that in some other disorders, as, for example, the association of duodenal ulcer to ABO (H) secretion and to the ABO and rhesus blood groups (Buckwalter, 1962 
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